Vimoc Bio and Haipai Pharma Explore Strategic Collaboration to Advance Wenzhou's Health Industry
VIVAVISION
Innovative Drug Developer
On the morning of November 28, Dr. Charles Xia, Chief Scientist of VIVAVISION, led a team to visit Haipai Pharmaceutical for business negotiations. Mr. Zhang Xiang, Chairman of Haipai Pharmaceutical, Ms. Cai Xiaolian, General Manager, along with the company's senior management team, warmly received them.
During the visit, the VIVAVISION delegation conducted a detailed inspection of Haipai Pharmaceutical's two major projects, the "Life Health Science and Technology Innovation Park" and the "Life Health Industry Park," and introduced VIVAVISION's innovative capabilities in new drug research and development.
Mr. Zhang Xiang also provided a detailed introduction to the development strategy and future development plans of Haipai Pharmaceuticals.
During the talks, both parties thoroughly explored the possibilities for future cooperation and reached preliminary consensus on multiple potential areas of collaboration. Both sides expressed optimism about the prospects of cooperation and look forward to jointly promoting the innovation and development of Wenzhou's large health industry through resource sharing and complementary advantages.